EIT Health`s CLOSE Project recognized by researchers from the National Institutes of Health (NIH)
Andrew A. Bremer (Eunice Kennedy Shriver National Institute of Child Health and Human Development) and Guillermo Arreaza-Rubin (National Institute of Diabetes and Digestive and Kidney Diseases) recently presented their Analysis of “Artificial Pancreas (AP) Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project” in the Journal of Diabetes Science and Technology.
The authors came up with a very positive evaluation of the comprehensive and integrated approach of CLOSE APplus: They state that the conception and design of CLOSE is very valuable as the project addresses an understudied topic. Incorporating key stakeholders, education, and health impact in the center of the APplus platform is novel and may very well be what is needed to achieve the widespread use of AP systems in people with type 2 diabetes (T2D). They expect that the outcome of CLOSE will inform the creation of future treatment guidelines and recommend the CLOSE approach to be applied to other emerging diabetes technologies by testing them in an „APplus-like model“.
CLOSE (Automated Glucose Control at Home for People with Chronic Disease) stands for a project designed to overcome artificial pancreas (AP) implementation barriers. The primary objective of the project is to develop superior risk-benefit and cost-benefit scenarios for AP operation thereby achieving a positive acceptance by users and caregivers and a high eligibility for reimbursement. In order to meet this objective the project will put the AP into the center of comprehensive product and service packages (APplus) specifically tailored to defined T2D patient groups and care environments. In the design of APplus solutions the project is going to realize an interactive collaboration with users, healthcare providers and other stakeholders in diabetes care.
The Article reviewed was published in September 2018 in the Journal of Diabetes Science and Technology under the leadership of the EIT Health Innovation Project consortium CLOSE (Freimut Schliess, et. al). The article was authored by partners from industry and academia and members of EIT Health’s leadership.
See the access options for the article here